Clinical News

Clinical Status

<div class="articleContainer"><div class="articleWrapper"><div class="articleContent"><h1 class="text title">Celgosivir: Phase II start</h1><div class="byline">WIR Staff</div><div class="date"></div></div></div></div>

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

MGI will begin next quarter a Canadian Phase II trial in treatment-naïve chronic HCV patients. ......

Hepatic

Infectious

Celgosivir: Phase II start

Featured Analysis

Articles by Category

Current Editions

Data Graphics

Discovery & Translation Analysis

Discovery & Translation

Hot Topics

BioCentury Podcasts

Special Reports & Presentations

White Papers

Analysis

BCIQ

Company Profiles

Product Profiles

Target Profiles

Financial Dashboards

BCIQ Data

All Events

East-West Healthcare Reception

Bio€quity Europe

Grand Rounds — U.S.

Grand Rounds — Europe

The BioCentury-BayHelix China Healthcare Summit

China Healthcare Summit

At the East-West Summit, you will meet key players looking to globalize innovation from across Asia.